Trial · NCT02912260
Adverse events69
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 69
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | MGL-3196 Main Study | 31 | 84 | 49 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Main Study | 4 | 41 | 4 |
| other | Diarrhoea | Gastrointestinal disorders | Extension Study | 2 | 31 | 6 |
| other | Nausea | Gastrointestinal disorders | MGL-3196 Main Study | 17 | 84 | 17 |
| other | Nausea | Gastrointestinal disorders | Placebo Main Study | 2 | 41 | 2 |
| other | Nausea | Gastrointestinal disorders | Extension Study | 0 | 31 | 0 |
| other | Abdominal Pain | Gastrointestinal disorders | MGL-3196 Main Study | 6 | 84 | 8 |
| other | Abdominal Pain | Gastrointestinal disorders | Placebo Main Study | 3 | 41 | 3 |
| other | Abdominal Pain | Gastrointestinal disorders | Extension Study | 0 | 31 | 0 |
| other | Abdominal Pain Upper | Gastrointestinal disorders | MGL-3196 Main Study | 7 | 84 | 9 |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Placebo Main Study | 1 | 41 | 2 |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Extension Study | 0 | 31 | 0 |
| other | Urinary tract infection | Infections and infestations | MGL-3196 Main Study | 9 | 84 | 10 |
| other | Urinary tract infection | Infections and infestations | Placebo Main Study | 4 | 41 | 6 |
| other | Urinary tract infection | Infections and infestations | Extension Study | 0 | 31 | 0 |
| other | Nasopharyngitis | Infections and infestations | MGL-3196 Main Study | 5 | 84 | 5 |
| other | Nasopharyngitis | Infections and infestations | Placebo Main Study | 2 | 41 | 3 |
| other | Nasopharyngitis | Infections and infestations | Extension Study | 3 | 31 | 3 |
| other | Influenza | Infections and infestations | MGL-3196 Main Study | 6 | 84 | 6 |
| other | Influenza | Infections and infestations | Placebo Main Study | 0 | 41 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02912260/events